BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/24/2022 8:11:15 AM | Browse: 198 | Download: 494
Publication Name World Journal of Clinical Cases
Manuscript ID 69882
Country China
Received
2021-07-29 02:59
Peer-Review Started
2021-07-29 03:05
To Make the First Decision
Return for Revision
2021-10-25 08:34
Revised
2021-11-03 03:33
Second Decision
2021-12-14 03:39
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2021-12-23 04:20
Articles in Press
2021-12-23 04:20
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2022-01-06 10:29
Publish the Manuscript Online
2022-01-24 08:11
ISSN 2307-8960 (online)
Open Access
Copyright ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Immunology
Manuscript Type Case Report
Article Title Iguratimod in treatment of primary Sjögren’s syndrome concomitant with autoimmune hemolytic anemia: A case report
Manuscript Source Unsolicited Manuscript
All Author List Juan Zhang, Xin Wang, Jing-Jing Tian, Rong Zhu, Rui-Xue Duo, Yi-Chen Huang and Hai-Li Shen
ORCID
Author(s) ORCID Number
Juan Zhang http://orcid.org/0000-0002-1724-0014
Xin Wang http://orcid.org/0000-0002-1925-5340
Jing-Jing Tian http://orcid.org/0000-0001-9034-1041
Rong Zhu http://orcid.org/0000-0001-9490-3347
Rui-Xue Duo http://orcid.org/0000-0002-9464-4776
Yi-Chen Huang http://orcid.org/0000-0001-9508-3555
Hai-Li Shen http://orcid.org/0000-0002-6774-6419
Funding Agency and Grant Number
Funding Agency Grant Number
Lanzhou Science and Technology Plan Project 2018-3-48
Lanzhou Talent Innovation and Entrepreneurship Project 2019-RC-35
2019 Special Fund for Doctoral Training of Lanzhou University Second Hospital YJS-BD-15
Corresponding Author Hai-Li Shen, Doctor, Chief Doctor, Department of Rheumatology, Lanzhou University Second Hospital, No.82, Cuiyingmen, Chengguan District, Lanzhou, 730030, Gansu, China, Lanzhou 730030, Gansu Province, China. shenhl_523@163.com
Key Words Autoimmune hemolytic anemia; Iguratimod; Primary Sjögren’s syndrome; Case report
Core Tip Primary Sjögren's syndrome (pSS) concomitant with autoimmune hemolytic anemia (AIHA) but without eye and mouth dryness is exceedingly rare. Iguratimod (IGU) has been widely used in the treatment of pSS. However, there are few reports about the application of IGU in pSS concomitant with AIHA. Here, we present the case of a patient with pSS concomitant with AIHA who was successfully treated with IGU. IGU was effective for and well tolerated by our patient with pSS concomitant with AIHA, and may be a promising therapy for treatment of this disease.
Publish Date 2022-01-24 08:11
Citation Zhang J, Wang X, Tian JJ, Zhu R, Duo RX, Huang YC, Shen HL. Iguratimod in treatment of primary Sjögren’s syndrome concomitant with autoimmune hemolytic anemia: A case report. World J Clin Cases 2022; 10(4): 1286-1290
URL https://www.wjgnet.com/2307-8960/full/v10/i4/1286.htm
DOI https://dx.doi.org/10.12998/wjcc.v10.i4.1286
Full Article (PDF) WJCC-10-1286.pdf
Full Article (Word) WJCC-10-1286.docx
CARE Checklist–2016 69882-CARE-Checklist–2016-revision.pdf
Manuscript File 69882_Auto_Edited.docx
Answering Reviewers 69882-Answering reviewers.pdf
Audio Core Tip 69882-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 69882-Conflict-of-interest statement.pdf
Copyright License Agreement 69882-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 69882-Grant application form(s).pdf
Signed Informed Consent Form(s) or Document(s) 69882-Signed-Informed-Consent-Form(s)-or-Document(s)-revision.pdf
Non-Native Speakers of English Editing Certificate 69882-Language certificate.pdf